06:54 AM EST, 11/04/2024 (MT Newswires) -- Chemours ( CC ) reported Q3 adjusted earnings Monday of $0.40 per diluted share, down from $0.43 a year earlier.

Analysts surveyed by Capital IQ expected $0.28.

Net sales for the quarter ended Sept. 30 were $1.50 billion, up from $1.49 billion a year earlier.

Analysts polled by Capital IQ expected $1.44 billion.

For Q4, the company said it expects net sales to fall in the mid- to high-single digits sequentially.

Shares of the company rose more than 10% in recent pre-bell activity.

Price: 19.69, Change: +1.87, Percent Change: +10.49